L-Carnitine Reduces Oxidative Stress and Promotes Cells Differentiation and Bone Matrix Proteins Expression in Human Osteoblast-Like Cells.
Aged
Aged, 80 and over
Antioxidants
/ metabolism
Bone Matrix
/ drug effects
Calcification, Physiologic
/ drug effects
Calcium-Calmodulin-Dependent Protein Kinase Type 2
/ metabolism
Carnitine
/ pharmacology
Cell Differentiation
/ drug effects
Cells, Cultured
Core Binding Factor Alpha 1 Subunit
/ metabolism
Female
Humans
Integrin-Binding Sialoprotein
/ metabolism
MAP Kinase Signaling System
/ drug effects
Mitogen-Activated Protein Kinases
/ metabolism
Osteoblasts
/ drug effects
Osteogenesis
/ drug effects
Osteopontin
/ metabolism
Oxidation-Reduction
Oxidative Stress
/ drug effects
Phosphorylation
/ drug effects
Proto-Oncogene Proteins c-akt
/ metabolism
Reactive Oxygen Species
/ metabolism
Sp7 Transcription Factor
/ metabolism
Up-Regulation
/ drug effects
Journal
BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173
Informations de publication
Date de publication:
2019
2019
Historique:
received:
07
11
2018
accepted:
23
12
2018
entrez:
26
2
2019
pubmed:
26
2
2019
medline:
14
6
2019
Statut:
epublish
Résumé
Bone fragility and associated fracture risk are major problems in aging. Oxidative stress and mitochondrial dysfunction play a key role in the development of bone fragility. Mitochondrial dysfunction is closely associated with excessive production of reactive oxygen species (ROS). L-Carnitine (L-C), a fundamental cofactor in lipid metabolism, has an important antioxidant property. Several studies have shown how L-C enhances osteoblastic proliferation and activity. In the current study, we investigated the potential effects of L-C on mitochondrial activity, ROS production, and gene expression involved in osteoblastic differentiation using osteoblast-like cells (hOBs) derived from elderly patients. The effect of 5mM L-C treatment on mitochondrial activity and L-C antioxidant activity was studied by ROS production evaluation and cell-based antioxidant activity assay. The possible effects of L-C on hOBs differentiation were assessed by analyzing gene and protein expression by Real Time PCR and western blotting, respectively. L-C enhanced mitochondrial activity and improved antioxidant defense of hOBs. Furthermore, L-C increased the phosphorylation of Ca
Identifiants
pubmed: 30800672
doi: 10.1155/2019/5678548
pmc: PMC6360619
doi:
Substances chimiques
Antioxidants
0
Core Binding Factor Alpha 1 Subunit
0
Integrin-Binding Sialoprotein
0
Reactive Oxygen Species
0
Sp7 Transcription Factor
0
Osteopontin
106441-73-0
Proto-Oncogene Proteins c-akt
EC 2.7.11.1
Calcium-Calmodulin-Dependent Protein Kinase Type 2
EC 2.7.11.17
Mitogen-Activated Protein Kinases
EC 2.7.11.24
Carnitine
S7UI8SM58A
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
5678548Références
J Biol Chem. 2001 Apr 27;276(17):14443-50
pubmed: 11278600
J Cell Biol. 2004 Jul 5;166(1):85-95
pubmed: 15226309
Am J Physiol Cell Physiol. 2004 Oct;287(4):C817-33
pubmed: 15355853
J Biol Chem. 2005 Feb 25;280(8):7049-59
pubmed: 15590632
Exp Aging Res. 2005 Jan-Mar;31(1):55-67
pubmed: 15842073
Calcif Tissue Int. 2005 Jun;76(6):458-65
pubmed: 15906015
Cell Metab. 2005 Jul;2(1):21-33
pubmed: 16054096
Cell Calcium. 2005 Sep-Oct;38(3-4):311-7
pubmed: 16087232
Biochem Biophys Res Commun. 2005 Oct 14;336(1):357-63
pubmed: 16139248
IUBMB Life. 2007 Jan;59(1):27-33
pubmed: 17365177
Calcif Tissue Int. 2008 Mar;82(3):221-8
pubmed: 18265928
J Gerontol A Biol Sci Med Sci. 2008 Oct;63(10):1027-33
pubmed: 18948552
Horm Metab Res. 2009 Nov;41(11):840-5
pubmed: 19598076
Trends Endocrinol Metab. 2010 Jun;21(6):369-74
pubmed: 20223679
Nat Rev Mol Cell Biol. 2010 Sep;11(9):621-32
pubmed: 20683470
Aging Cell. 2011 Apr;10(2):191-7
pubmed: 21210937
Curr Drug Metab. 2011 Sep;12(7):667-78
pubmed: 21561431
J Cell Biol. 2011 Jul 11;194(1):7-15
pubmed: 21746850
Swiss Med Wkly. 2012 Aug 17;142:w13659
pubmed: 22903797
Transl Res. 2013 Feb;161(2):73-84
pubmed: 23138103
Curr Osteoporos Rep. 2014 Sep;12(3):366-75
pubmed: 24894149
Dose Response. 2014 Jan 31;12(2):288-341
pubmed: 24910588
FEBS J. 2014 Aug;281(16):3656-66
pubmed: 24961731
Bone. 2015 Feb;71:145-54
pubmed: 25464126
Food Chem. 2015 May 15;175:601-8
pubmed: 25577125
Rev Endocr Metab Disord. 2015 Jun;16(2):93-8
pubmed: 25577163
Stem Cells Dev. 2015 May 15;24(10):1150-63
pubmed: 25603196
Oxid Med Cell Longev. 2015;2015:646171
pubmed: 25838869
Int J Biol Macromol. 2015;78:202-8
pubmed: 25881954
Calcif Tissue Int. 2015 Sep;97(3):281-91
pubmed: 26048282
J Cell Physiol. 2016 Mar;231(3):587-96
pubmed: 26206105
Br J Dermatol. 2016 Oct;175 Suppl 2:26-29
pubmed: 27667312
World J Biol Chem. 2017 Feb 26;8(1):86-94
pubmed: 28289521
J Exp Biol. 2017 Apr 1;220(Pt 7):1170-1180
pubmed: 28356365
J Transl Med. 2017 Jun 7;15(1):132
pubmed: 28592272
Cell Death Differ. 2018 Feb;25(2):229-240
pubmed: 28914882
Ann N Y Acad Sci. 2017 Dec;1409(1):79-84
pubmed: 29044594
Calcif Tissue Int. 1985 Sep;37(5):453-460
pubmed: 29372293
J Bone Miner Res. 1994 Mar;9(3):355-66
pubmed: 8191929